Neovacs S.A. (ALNEV) — Cash Flow-to-Debt Ratio
Neovacs S.A. (ALNEV) has a Cash Flow-to-Debt Ratio of -0.58x as of June 2025, meaning its operating cash flow of €-2.43 Million could theoretically repay -1% of its total liabilities (€4.18 Million) in one year. See free cash flow generation of Neovacs S.A. to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neovacs S.A. Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Neovacs S.A. across 18 annual periods. Also explore Neovacs S.A. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Neovacs S.A. (2007–2024)
Year-by-year debt coverage analysis for Neovacs S.A.. For market capitalisation and broader financial context, see ALNEV stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.90x | €-3.60 Million | €4.01 Million | ▼ -74.3% |
| 2023 | -0.52x | €-1.91 Million | €3.71 Million | ▲ +41.5% |
| 2022 | -0.88x | €-4.45 Million | €5.05 Million | ▲ +58.7% |
| 2021 | -2.13x | €-9.91 Million | €4.65 Million | ▲ +5.6% |
| 2020 | -2.26x | €-5.65 Million | €2.50 Million | ▼ -33.7% |
| 2019 | -1.69x | €-8.10 Million | €4.80 Million | ▲ +39.1% |
| 2018 | -2.77x | €-13.31 Million | €4.80 Million | ▼ -110.4% |
| 2017 | -1.32x | €-14.26 Million | €10.82 Million | ▲ +3.2% |
| 2016 | -1.36x | €-11.00 Million | €8.08 Million | ▲ +8.2% |
| 2015 | -1.48x | €-7.69 Million | €5.18 Million | ▲ +35.7% |
| 2014 | -2.31x | €-8.05 Million | €3.49 Million | ▼ -38.1% |
| 2013 | -1.67x | €-7.00 Million | €4.19 Million | ▲ +31.6% |
| 2012 | -2.44x | €-6.33 Million | €2.59 Million | ▲ +31.6% |
| 2011 | -3.57x | €-8.63 Million | €2.41 Million | ▼ -6.1% |
| 2010 | -3.37x | €-8.10 Million | €2.40 Million | ▼ -106.6% |
| 2009 | -1.63x | €-7.95 Million | €4.88 Million | ▲ +20.4% |
| 2008 | -2.05x | €-4.49 Million | €2.19 Million | ▲ +3.5% |
| 2007 | -2.12x | €-4.32 Million | €2.04 Million | — |